Events

This presentation is about our revised guidance on advertising health services which involve cosmetic injectables.

This presentation is an introduction to the new in-house IVD notification form and notification template.

We will provide an overview of the Medicines Repurposing Program and how interested stakeholders can propose potential new therapeutic uses of existing medicines.

We showcased changes to the Clinical Trials Notifications (CTN) form and explained how the review of CTNs for the highest risk medical device clinical trials will operate in practice.

This presentation describes the data requirements and the assessment approach need for in-house IVDs, including Companion Diagnostics.

This presentation describes the data requirements and the assessment approach need for in-house IVDs, including Companion Diagnostics.

We will provide an overview of the Medicines Repurposing Program and how interested stakeholders can propose potential new therapeutic uses of existing medicines.

Watch our webinar that provides information for prescribers on the vaping reforms, in partnership with the Royal Australian College of General Practitioners (RACGP) and Quit Centre,

This webinar provides information on the TGA’s public consultation on the impacts, challenges and opportunities relating to medicine shortages.

Advisory Committee on Medicines (ACM) meeting

Learn about vaping reforms and how these will impact consumers, suppliers and health professionals.

Advisory Committee on Medicines (ACM) meeting

Advisory Committee on Vaccines (ACV) meeting

An update on the Australian UDI implementation, and the real-world benefits of the UDI adoption in the US healthcare system.

Advisory Committee on Biologicals (ACB) meeting

Advisory Committee on Complementary Medicines (ACCM) meeting

Advisory Committee on Medicines (ACM) meeting

Advisory Committee on Vaccines (ACV) meeting

Update on what we know so far, next 6-month plan and what you can do to get involved.

Learn about the new Medical Device Vigilance Program that we will be piloting, and volunteer to participate.

Advisory Committee on Biologicals (ACB) meeting

Webinar to understand recent changes to safety issue reporting requirements as outlined in the Pharmacovigilance responsibilities of medicine sponsors guidance.

Attend this webinar to understand recent changes to safety issue reporting requirements as outlined in the Pharmacovigilance responsibilities of medicine sponsors guidance.

Register to hear insights from our Good Clinical Practice Inspection Program.

This presentation provides an update on the GCP Inspection Program implemented in 2022.